Europe Diagnostic Antibodies Market Size, Share & Industry Analysis, By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies, and Others), By Technology (Flow Cytometry, ELISA, Immunohistochemistry, Western Blot, and Others), By Source (Mouse, Rabbit, Goat, Human, and Others), By Application (Oncology, Immunology, Infectious Diseases, and Others), By End-user (Hospitals & Diagnostic Laboratories, Pharmaceutical and Diagnostic Companies {IVD Companies and Others}, and Academic & Research Institutions), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113081

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence/ Incidence of Key Disease, By Countries, 2024
2. Overview of Primary vs. Secondary Antibodies
3. Technological Advancements in Diagnostic Antibodies
4. Innovations in Development of Antibodies
5. List of Key CDMOs Offering Diagnostic Antibodies Services
6. New Product Launches, By Key Players
7. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
8. Type of Antibodies Used in the Specific Technology – Overview
9. Impact of COVID-19 on the Market
Europe Diagnostic Antibodies Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Monoclonal Antibodies
  2. Polyclonal Antibodies
  3. Recombinant Antibodies
  4. Conjugated Antibodies
  5. Others
2. Market Analysis, Insights and Forecast – By Technology
  1. Flow Cytometry
  2. ELISA
  3. Immunohistochemistry
  4. Western Blot
  5. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Mouse
  2. Rabbit
  3. Goat
  4. Human
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Immunology
  3. Infectious Diseases
  4. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Diagnostic Laboratories
  2. Pharmaceutical and Diagnostic Companies
    1. IVD Companies
    2. Others
  3. Academic & Research Institutions
6. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Competitive Analysis
1. Europe Market Share Analysis (2024)
2. Company Profiles
  1. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Danaher Corporation
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Bio-Rad Laboratories, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Agilent Technologies, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Merck KgaA
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. BioGenex
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Biocult B.V.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. EXBIO Praha, a.s.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. BioPorto A/S
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  11. Creative Diagnostics
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence/ Incidence of Key Disease, By Countries, 2024
2. Overview of Primary vs. Secondary Antibodies
3. Technological Advancements in Diagnostic Antibodies
4. Innovations in Development of Antibodies
5. List of Key CDMOs Offering Diagnostic Antibodies Services
6. New Product Launches, By Key Players
7. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
8. Type of Antibodies Used in the Specific Technology – Overview
9. Impact of COVID-19 on the Market
Europe Diagnostic Antibodies Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Monoclonal Antibodies
  2. Polyclonal Antibodies
  3. Recombinant Antibodies
  4. Conjugated Antibodies
  5. Others
2. Market Analysis, Insights and Forecast – By Technology
  1. Flow Cytometry
  2. ELISA
  3. Immunohistochemistry
  4. Western Blot
  5. Others
3. Market Analysis, Insights and Forecast – By Source
  1. Mouse
  2. Rabbit
  3. Goat
  4. Human
  5. Others
4. Market Analysis, Insights and Forecast – By Application
  1. Oncology
  2. Immunology
  3. Infectious Diseases
  4. Others
5. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Diagnostic Laboratories
  2. Pharmaceutical and Diagnostic Companies
    1. IVD Companies
    2. Others
  3. Academic & Research Institutions
6. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Competitive Analysis
1. Europe Market Share Analysis (2024)
2. Company Profiles
  1. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Danaher Corporation
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Bio-Rad Laboratories, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Agilent Technologies, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Merck KgaA
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. BioGenex
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Biocult B.V.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. EXBIO Praha, a.s.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. BioPorto A/S
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  11. Creative Diagnostics
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Europe Diagnostic Antibodies Market Revenue Breakdown (USD billion, %) by Country/ Sub-Region, 2024 & 2032

Figure 2: Europe Diagnostic Antibodies Market Value Share (%), by Type, 2024 & 2032

Figure 3: Europe Diagnostic Antibodies Market Value Share (%), by Technology, 2024 & 2032

Figure 4: Europe Diagnostic Antibodies Market Value Share (%), by Source, 2024 & 2032

Figure 5: Europe Diagnostic Antibodies Market Value Share (%), by Application, 2024 & 2032

Figure 6: Europe Diagnostic Antibodies Market Value Share (%), by End-user, 2024 & 2032

Figure 7: Europe Diagnostic Antibodies Market Value (USD billion), by Country/ Sub-Region, 2024 & 2032

Figure 8: Europe Market Share Analysis (2024)

List of Tables

Table 1: Europe Diagnostic Antibodies Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2: Europe Diagnostic Antibodies Market Revenue (USD billion) Forecast, by Technology, 2019–2032

Table 3: Europe Diagnostic Antibodies Market Revenue (USD billion) Forecast, by Source, 2019–2032

Table 4: Europe Diagnostic Antibodies Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 5: Europe Diagnostic Antibodies Market Revenue (USD billion) Forecast, by End-user 2019–2032

Table 6: Europe Diagnostic Antibodies Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 121

(Offer valid till 15^th Dec 2025)

Download Free Sample

Security Code

Growth Advisory Services

How can we help you uncover new opportunities and scale faster?

Clients

Related Reports

Flow Cytometry Market

Monoclonal Antibody Therapy Market

Antibody Drug Conjugate Therapeutics Market

Clinical Laboratory Services Market

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)

sales@fortunebusinessinsights.com